Mercados españoles cerrados

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
132,90+0,22 (+0,17%)
Al cierre: 04:00PM EDT
132,99 +0,10 (+0,07%)
Después del cierre: 07:56PM EDT

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Sector(es)Healthcare
SectorBiotechnology
Empleados a tiempo completo5600

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Stephane BancelCEO & Director4,55M300,71M1973
Dr. Stephen Hoge M.D.President1,92MN/A1977
Mr. James M. MockChief Financial Officer1,4MN/A1977
Ms. Shannon Thyme KlingerChief Legal Officer & Corporate Secretary1,39MN/A1971
Dr. Jerh Collins Ph.D.Chief Technical Operations & Quality OfficerN/AN/A1967
Mr. Brad MillerChief Information OfficerN/AN/A1974
Ms. Lavina Talukdar CFASenior VP & Head of Investor RelationsN/AN/AN/A
Colleen HusseySenior Director of Corporate CommunicationsN/AN/AN/A
Ms. Tracey FranklinChief Human Resources OfficerN/AN/A1981
Dr. Melanie Ivarsson M.B.A., Ph.D.Chief Development OfficerN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Gobierno corporativo

El ISS Governance QualityScore de Moderna, Inc., a día 1 de mayo de 2024, es 9. Las puntuaciones base son Auditoría: 7; Tablero: 7; Derechos de los accionistas: 9; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.